Chemoinformaics analysis of 6-METHOXYFURO[2,3-H]CHROMEN-2-ONE
Molecular Weight | 216.192 | nRot | 1 |
Heavy Atom Molecular Weight | 208.128 | nRig | 16 |
Exact Molecular Weight | 216.042 | nRing | 3 |
Solubility: LogS | -3.557 | nHRing | 2 |
Solubility: LogP | 1.971 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 1 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 2 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 13 |
No. of Oxygen atom | 4 | No. of Arom Bond | 15 |
nHA | 4 | APOL | 28.5823 |
nHD | 0 | BPOL | 14.1017 |
QED | 0.586 |
Synth | 2.505 |
Natural Product Likeliness | 1.324 |
NR-PPAR-gamma | 0.177 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.005 |
Pgp-sub | 0.018 |
HIA | 0.009 |
CACO-2 | -4.756 |
MDCK | 0.0000319 |
BBB | 0.049 |
PPB | 0.796863 |
VDSS | 0.917 |
FU | 0.149143 |
CYP1A2-inh | 0.988 |
CYP1A2-sub | 0.905 |
CYP2c19-inh | 0.547 |
CYP2c19-sub | 0.095 |
CYP2c9-inh | 0.273 |
CYP2c9-sub | 0.809 |
CYP2d6-inh | 0.803 |
CYP2d6-sub | 0.785 |
CYP3a4-inh | 0.805 |
CYP3a4-sub | 0.2 |
CL | 12.973 |
T12 | 0.759 |
hERG | 0.008 |
Ames | 0.308 |
ROA | 0.382 |
SkinSen | 0.185 |
Carcinogencity | 0.906 |
EI | 0.081 |
Respiratory | 0.93 |
NR-Aromatase | 0.778 |
Antiviral | No |
Prediction | 0.629918 |